Healthcare

Brent Ahrens

General Partner / West Coast

Since 1999

Brent leads investments in an array of healthcare companies, with a focus on biopharma and medtech. Prior to joining Canaan, Brent worked in both commercial and technical roles at General Surgical Innovations, Ethicon Endo-Surgery (J&J), and IAP Research. He also has several surgical instrument patents to his credit. Brent earned an MBA from the Tuck School of Business at Dartmouth College after graduating with a B.S. and M.S. in Mechanical Engineering from the University of Dayton.

Brent in 5

Origins: Born in Ohio

Travel: Enjoy traveling around this great country - & others too!

Talent: Used to know how to fix cars

Dream Job: Ski instructor or wood worker

Bucket List: Travel in space & attend The Masters

Investments

Current

  • Abyrx
  • Axcelius I/II
  • EndoGastric Solutions
  • Grey Wolf Therapeutics
  • Iterum Therapeutics
    IPO (ITRM)
  • OncoLinea Pharmaceuticals
  • Pathios Therapeutics
  • Relievant Medsystems
  • Semnur Pharmaceuticals
    Acquired by Sorrento Therapeutics
  • Transposon Therapeutics
  • Previous

    • Calixa Therapeutics
      Acquired by Cubist Pharmaceuticals
    • Cerexa
      Acquired by Forest Labs
    • Data Sciences International
      Acquired by Harvard Bioscience
    • DexCom
      IPO
    • Durata Therapeutics
      IPO
    • Elevation Pharmaceuticals
      Acquired by Sunovion Pharmaceuticals
    • Peninsula Pharmaceuticals
      Acquired by Johnson & Johnson
    • Revivant
      Acquired by ZOLL
    • Spinifex Pharmaceuticals
      Acquired by Novartis
    • Unchained Labs
      Acquired by Carlyle

    Latest

    Brent in 5

    Origins: Born in Ohio

    Travel: Enjoy traveling around this great country - & others too!

    Talent: Used to know how to fix cars

    Dream Job: Ski instructor or wood worker

    Bucket List: Travel in space & attend The Masters